Can-Fite Biopharma: $9 Price Target from Dawson James

September 18, 2019

Can-Fite BioPharma Ltd. (NYSE American: CANF) is an advanced clinical stage drug development company with a platform technology that addresses multi-billion-dollar markets in the treatment of autoimmune inflammatory diseases including Rheumatoid Arthritis and Psoriasis, and liver diseases including advanced liver cancer and NASH.

Spotlight

CorePharma LLC

CorePharma, founded in 1998, is a developer, manufacturer and marketer of high-quality, targeted, generic prescription pharmaceuticals across a variety of dosage forms and therapeutic categories.

OTHER VIDEOS

Filling, closing and labeling compact machines for microtubes

video | November 28, 2022

Dara Pharma designs state-of-the-art solutions for processing diagnostics reagents. We offer different equipment for this format, which is often filled in tubes, microtubes,...

Watch Now

Revolutionizing visual inspection in pharma through AI

video | November 29, 2022

That is why we have launched our AI-powered visual inspection software solution with full commitment to help pharmaceutical companies improve their product quality while reducing False Rejects and costs to a minimum....

Watch Now

User-Friendly App for pharmaceutical deliveries to your doorstep

video | November 29, 2022

With just a few clicks get the convenience of pharmaceutical deliveries to your doorstep. Experience a user-friendly app!...

Watch Now

The Future of Pharmacy Management Software

video | November 17, 2022

Welcome to the future of pharmacy management software! Axys is built from the ground up on the most modern technology. Not the most modern technology in long-term care....

Watch Now

Spotlight

CorePharma LLC

CorePharma, founded in 1998, is a developer, manufacturer and marketer of high-quality, targeted, generic prescription pharmaceuticals across a variety of dosage forms and therapeutic categories.

Events